Fingernail Onychomycosis Treatment Guidelines

Introduction to Treatment Options

The American College of Dermatology recommends oral terbinafine 250 mg once daily for 6 weeks as the first-line treatment for fingernail onychomycosis caused by dermatophytes 1, 2

Mycological confirmation is mandatory before initiating any antifungal therapy through KOH preparation, fungal culture, or nail biopsy to confirm dermatophyte infection, as recommended by the British Journal of Dermatology 3

Terbinafine 250 mg once daily for 6 weeks is the standard regimen for fingernail infections, with a complete cure rate of 55% versus 26% for itraconazole at 72 weeks, according to the Praxis Medical Insights 1, 2
Terbinafine demonstrates fungicidal activity against dermatophytes with very low minimum inhibitory concentrations, making it significantly more effective than fungistatic azoles 1, 2
Minimal drug-drug interactions compared to azole antifungals, with only cytochrome P450 2D6 substrates requiring caution 1, 2

If terbinafine is contraindicated or not tolerated, itraconazole is the second-line alternative, with pulse therapy (400 mg daily for 1 week per month for 2 pulses) or continuous therapy (200 mg daily for 12 weeks) options, as recommended by the British Journal of Dermatology 5, 1
Itraconazole has significant interactions with statins, requiring careful monitoring or temporary dose adjustment 4

Topical therapy alone is appropriate for mild, superficial, or distal onychomycosis involving less than 50% of the nail plate without matrix involvement, according to the British Journal of Dermatology 5
Efinaconazole 10% solution and tavaborole 5% solution are FDA-approved topical agents for the treatment of onychomycosis, with mycological cure rates approaching 50% and complete cure in 15% 4

Re-evaluate patients 3-6 months after treatment initiation, with assessment including both clinical improvement and mycological cure (negative microscopy and culture), as recommended by the Praxis Medical Insights 1, 2, 3, 4
Follow-up period of at least 48 weeks from start of treatment is ideal to identify potential relapse 3, 4

If first course of terbinafine fails, confirm the infection is due to dermatophytes and repeat pre-treatment checks (liver function tests and complete blood count) before resuming terbinafine 250 mg daily for another 6 weeks, according to the Praxis Medical Insights 4
If second course fails, switch to itraconazole as second-line alternative, with 200 mg daily for 12 weeks or 400 mg daily for 1 week per month for 2 pulses options 4

If mycological testing confirms Candida species, itraconazole becomes the first-line treatment, with a superior cure rate of 92% versus 40% for terbinafine in Candida infections, according to the Praxis Medical Insights 4

Decontaminate or replace contaminated footwear, apply antifungal powders inside shoes regularly, and consider periodic spraying of terbinafine solution into shoes to prevent recurrence, as recommended by the Praxis Medical Insights 4